AM095 is primarily utilized in research settings to study its effects on the cardiovascular system, particularly its role as a potent and selective antagonist of the prostaglandin D2 receptor (DP1). It is employed to investigate the mechanisms underlying vascular smooth muscle relaxation and its potential implications in managing conditions like hypertension and other cardiovascular diseases. Researchers also explore its impact on inflammatory processes, as DP1 receptor modulation is linked to inflammatory responses. Additionally, AM095 is used in preclinical studies to assess its therapeutic potential in treating disorders related to prostaglandin signaling pathways. Its application helps in understanding the broader physiological and pathological roles of prostaglandin receptors in the body.